A phase I/II double-blind, placebo-controlled study of recombinant human interleukin-11 for mucositis and acute GVHD prevention in allogeneic stem cell transplantation. (Q53975414)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A phase I/II double-blind, placebo-controlled study of recombinant human interleukin-11 for mucositis and acute GVHD prevention in allogeneic stem cell transplantation. |
scientific article |
Statements
A phase I/II double-blind, placebo-controlled study of recombinant human interleukin-11 for mucositis and acute GVHD prevention in allogeneic stem cell transplantation. (English)
1 reference
Antin JH
1 reference
Lee SJ
1 reference
Neuberg D
1 reference
Alyea E
1 reference
Soiffer RJ
1 reference
Sonis S
1 reference
Ferrara JL
1 reference
1 March 2002
1 reference
29
1 reference
5
1 reference
373-377
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference